The Exoskeleton market size was valued at USD 280.00 million in 2018, increased to USD 480.13 million in 2024, and is anticipated to reach USD 1,585.31 million by 2032, at a CAGR of 16.15% during the forecast period.
The Exoskeleton market is driven by leading players such as Ekso Bionics, ARMASTEC PTE. LTD, Hocoma, Lockheed Martin Corporation, Suit X, Rex Bionics Plc., RB3D, ReWalk Robotics, Cyberdyne, Inc., ActiveLink (Panasonic Corporation), and DIH Medical. These companies are focused on technological innovations, strategic partnerships, and expanding their product portfolios to cater to the growing demand across healthcare, industrial, and defense sectors. North America leads the global market with a dominant share of approximately 44.7% in 2024, supported by advanced healthcare infrastructure, significant defense investments, and strong industrial adoption. Asia Pacific follows as the fastest-growing region, driven by rapid industrialization and rising healthcare investments.
Market Insights
The Exoskeleton market was valued at USD 280.00 million in 2018, reached USD 480.13 million in 2024, and is projected to reach USD 1,585.31 million by 2032, growing at a CAGR of 16.15% during the forecast period.
Increasing demand for mobility assistance and rehabilitation solutions in healthcare, along with growing industrial applications to prevent workplace injuries, are key drivers fueling market growth.
Integration of AI and IoT technologies, along with rising adoption in military and industrial sectors, are shaping market trends and creating new opportunities for advanced, adaptive exoskeleton designs.
Leading companies like Ekso Bionics, ReWalk Robotics, and Cyberdyne, Inc. are focusing on product innovation and global expansion, but high costs and regulatory challenges continue to restrain market accessibility.
North America holds the largest market share at 44.7% in 2024, followed by Asia Pacific with 26.4%; the mobile and lower body segments dominate the market by mobility and extremity.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
In the Exoskeleton market, the mobile segment dominates with the largest market share in 2024. Mobile exoskeletons are highly preferred due to their flexibility, enhanced user mobility, and ease of integration across various applications, especially in healthcare and industrial settings. The rising demand for wearable and lightweight solutions to support rehabilitation and assist physically challenged individuals significantly drives this segment. Additionally, the increasing use of mobile exoskeletons in physically intensive jobs to reduce fatigue and prevent workplace injuries further propels its market growth.
For instance, Ekso Bionics’ EksoNR exoskeleton has been deployed in over 375 rehabilitation centers globally and supports up to 100 therapy sessions per charge.
By Extremity:
The lower body segment holds the largest market share in the extremity classification of the Exoskeleton market. Lower body exoskeletons are widely utilized in rehabilitation centers and the military sector for gait training, mobility assistance, and physical endurance enhancement. The growing incidences of spinal cord injuries and mobility impairments, coupled with the expanding adoption of robotic rehabilitation technologies, drive this segment’s dominance. Moreover, advancements in sensor technologies and lightweight materials are contributing to the increased deployment of lower body exoskeletons for both therapeutic and industrial purposes.
For instance, ReWalk Robotics’ ReWalk Personal 6.0 lower limb system enables users with spinal cord injuries to walk independently at speeds of up to 0.71 meters per second.
By End-use:
Within the Exoskeleton market, the healthcare segment leads with the highest market share, supported by growing demand for rehabilitation solutions and mobility assistance for elderly and disabled patients. Exoskeletons in healthcare are extensively used for physical therapy, post-stroke recovery, and gait training, offering substantial benefits in improving patient mobility and reducing recovery time. The increasing prevalence of musculoskeletal disorders and neurological conditions further accelerates the adoption of exoskeletons in hospitals and rehabilitation centers. Additionally, favorable reimbursement policies and continuous technological improvements are expected to bolster the growth of this segment.
Market Overview
Rising Demand for Rehabilitation and Mobility Solutions
The increasing prevalence of mobility impairments, spinal cord injuries, and age-related physical disabilities significantly drives the demand for exoskeletons, particularly in the healthcare sector. These devices offer effective support in rehabilitation programs by improving patient mobility, reducing recovery time, and enhancing physical endurance. Growing geriatric populations worldwide further contribute to this trend, as exoskeletons are increasingly used to assist elderly individuals in maintaining independence and improving their quality of life. The healthcare industry’s growing focus on advanced, patient-centric solutions continues to accelerate market growth.
For instance, Cyberdyne’s HAL exoskeleton has been clinically proven to increase walking distance by 120 meters per session in spinal cord injury patients after 12 weeks of training.
Growing Industrial Applications to Prevent Workplace Injuries
Exoskeletons are gaining traction in industrial environments to reduce physical strain and prevent work-related injuries among laborers, especially in sectors like manufacturing, construction, and logistics. These wearable systems enhance worker productivity by providing back support, reducing muscle fatigue, and enabling the safe handling of heavy equipment. Increasing employer awareness regarding workplace safety and the need to comply with stringent occupational health regulations are further fueling demand. As industries prioritize worker well-being and operational efficiency, the adoption of exoskeletons is expected to expand steadily.
For instance, the Laevo V2 industrial exoskeleton has been shown to reduce back muscle electrical activity by 48 millivolts and supports workers lifting 15 kilograms continuously over 8 hours with less fatigue.
Rapid advancements in robotics, sensor technologies, and lightweight materials have significantly improved the design, efficiency, and comfort of exoskeletons. Innovations such as AI-driven control systems, improved battery life, and enhanced mobility support are making exoskeletons more accessible and functional across various sectors. These technological improvements are not only increasing adoption in healthcare and industrial fields but are also paving the way for new military applications. Continued research and development efforts are expected to introduce more affordable, adaptable, and user-friendly exoskeleton solutions, driving further market growth.
Key Trends & Opportunities
Expansion in Military and Defense Applications
The military sector is increasingly adopting exoskeletons to enhance soldier performance, reduce fatigue, and improve load-carrying capacity during extended missions. These systems offer strategic advantages by enabling soldiers to move more efficiently while carrying heavy gear. The focus on developing powered exoskeletons with advanced mobility and combat support capabilities presents a significant growth opportunity. Defense investments in wearable robotics for improving mission effectiveness and reducing injury risks are likely to strengthen this trend, positioning the military segment as a lucrative area for future market expansion.
For instance, Lockheed Martin’s ONYX exoskeleton has been successfully tested to support loads of 90 kilograms and shows a reduction in oxygen consumption by 0.25 liters per minute during load carriage.
Integration with Artificial Intelligence and IoT
The growing integration of artificial intelligence (AI) and Internet of Things (IoT) technologies is transforming the exoskeleton landscape. AI-powered exoskeletons enable adaptive, real-time motion assistance based on user behavior and physical needs, enhancing safety and efficiency. IoT connectivity allows seamless monitoring of device performance and patient progress in healthcare settings. These technological synergies offer opportunities for developing smarter, more responsive systems that can be customized to individual requirements, making exoskeletons increasingly attractive across multiple end-use industries.
For instance, SuitX’s ShieldX exoskeleton processes sensor data every 200 milliseconds and delivers support torque of up to 35 newton-meters, easing user strain during manual material handling.
Key Challenges
High Cost and Limited Accessibility
One of the primary challenges in the exoskeleton market is the high cost of development, production, and maintenance, which restricts accessibility, particularly for small businesses and individual patients. The advanced technology, specialized components, and complex engineering contribute to the steep pricing, limiting widespread adoption. Additionally, the lack of standardized reimbursement policies in several regions further hampers market penetration, especially in healthcare. Efforts to develop cost-effective models and improve affordability will be essential to unlocking the market’s full potential.
Technical Limitations and Operational Constraints
Despite significant advancements, current exoskeletons still face technical limitations, including restricted battery life, limited load capacity, and potential mechanical failures. These constraints can reduce user comfort and overall system reliability, particularly in demanding industrial or military environments. Moreover, many devices require extensive training for effective and safe usage, which can pose operational challenges. Addressing these technical gaps through continuous innovation and enhanced user training will be critical for sustaining long-term market growth.
Regulatory and Safety Compliance Issues
Strict regulatory requirements for medical and industrial exoskeletons present another key challenge for market players. Obtaining safety certifications and regulatory approvals can be time-consuming and costly, delaying product launches and market entry. Inconsistent standards across regions further complicate global distribution efforts. Manufacturers must navigate complex approval processes while ensuring product safety, reliability, and efficacy. Strengthening regulatory frameworks and harmonizing standards worldwide would help streamline the commercialization of exoskeleton technologies.
Regional Analysis
North America
North America dominates the Exoskeleton market with the largest market share of approximately 44.7% in 2024, driven by advanced healthcare infrastructure, strong industrial adoption, and substantial investments in defense applications. The market in this region was valued at USD 126.34 million in 2018 and reached USD 214.82 million in 2024, with expectations to hit USD 712.21 million by 2032, expanding at a CAGR of 16.2%. High awareness, supportive reimbursement policies, and continuous technological advancements contribute significantly to market growth in North America, particularly in the United States.
Europe
Europe holds a significant market share of around 18.5% in 2024, supported by increasing adoption of exoskeletons in rehabilitation centers and the rising aging population. The market was valued at USD 54.46 million in 2018 and grew to USD 88.47 million in 2024, with projections to reach USD 266.76 million by 2032, progressing at a CAGR of 14.8%. Key growth factors include government initiatives promoting robotic rehabilitation, expanding industrial applications, and growing demand for mobility aids across countries like Germany, France, and the United Kingdom.
Asia Pacific
Asia Pacific is the fastest-growing region in the Exoskeleton market, accounting for approximately 26.4% market share in 2024. The market size rose from USD 71.12 million in 2018 to USD 127.16 million in 2024, and is expected to reach USD 458.03 million by 2032, expanding at a robust CAGR of 17.4%. Rapid industrialization, increasing investment in healthcare infrastructure, and rising awareness regarding robotic mobility solutions drive this growth. Countries like China, Japan, and South Korea are leading the regional market, supported by strong research and development activities.
Latin America
Latin America captures a modest market share of approximately 5.0% in 2024, with growing interest in exoskeletons for industrial safety and rehabilitation purposes. The market expanded from USD 14.34 million in 2018 to USD 24.29 million in 2024, and is projected to reach USD 73.83 million by 2032, advancing at a CAGR of 15.0%. Brazil and Mexico are key contributors, driven by increasing healthcare investments and gradual technological adoption. The region presents growth potential as awareness and accessibility to exoskeleton technologies improve over time.
Middle East
The Middle East holds a market share of around 3.4% in 2024, supported by emerging healthcare applications and rising demand for innovative rehabilitation solutions. The regional market grew from USD 10.36 million in 2018 to USD 16.61 million in 2024, and is anticipated to reach USD 50.09 million by 2032, registering a CAGR of 14.9%. Market expansion is driven by increased investments in modern healthcare facilities and growing adoption in the defense sector, particularly in countries like the United Arab Emirates and Saudi Arabia.
Africa
Africa accounts for the smallest market share of approximately 2.1% in 2024 but shows a steady growth trajectory. The market progressed from USD 3.39 million in 2018 to USD 8.77 million in 2024, with projections to reach USD 24.40 million by 2032, growing at a CAGR of 13.7%. Limited access to advanced rehabilitation technology and lower healthcare spending currently constrain market growth. However, increasing awareness of mobility assistance devices and gradual improvement in medical infrastructure across key African nations present future growth opportunities.
Market Segmentations:
By Mobility
Mobile
Fixed/Stationary
By Extremity
Upper Body
Lower Body
Full Body
By End-use
Healthcare
Military
Industry
By Technology
Powered
Non-powered
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
The Exoskeleton market is highly competitive, characterized by the presence of established players and emerging companies striving for technological advancement and market share. Key companies such as Ekso Bionics, ARMASTEC PTE. LTD, Hocoma, Lockheed Martin Corporation, Suit X, Rex Bionics Plc., RB3D, ReWalk Robotics, Cyberdyne, Inc., ActiveLink (Panasonic Corporation), and DIH Medical are actively investing in research and development to introduce innovative, lightweight, and AI-integrated exoskeletons. These companies focus on expanding their product portfolios and enhancing device functionality to meet the growing demand in healthcare, industrial, and defense sectors. Strategic collaborations, mergers, and acquisitions are common in this space as firms aim to strengthen their technological capabilities and global footprint. Continuous product advancements, along with efforts to make exoskeletons more affordable and accessible, are shaping the competitive dynamics of the market. Intense competition encourages innovation, pushing manufacturers to develop user-friendly, energy-efficient, and application-specific exoskeleton solutions.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In February 2025, DIH Holding US, Inc. expanded its strategic partnership with Zahrawi Group (MTC Company) to include Saudi Arabia, strengthening its collaboration across four Gulf countries. This expansion enhances the distribution of DIH’s advanced robotic rehabilitation solutions, leveraging Zahrawi Group’s healthcare expertise.
In January 2025, DIH Holding US, Inc. partnered with Nobis Rehabilitation Partners to integrate the Andago overground gait and balance training device into all newly established Nobis hospitals. This collaboration enhances rehabilitation standards, providing patients with advanced treatment while ensuring safety for both patients and therapy teams.
In November 2024, Hyundai Motor and Kia’s Robotics LAB introduced the X-ble Shoulder, a wearable industrial robot that enhances worker safety and efficiency. It reduces musculoskeletal strain, augments upper arm strength, and ensures user comfort during overhead tasks.
In June 2024, Ekso Bionics partnered with Shepherd Center to integrate EksoNR and Ekso Indego exoskeletons into its rehabilitation network, advancing research and training programs for mobility-impaired patients. This collaboration aims to enhance clinical practices and support individuals transitioning from hospital to home with exoskeleton technology.
In February 2024, DIH Holding US, Inc. merged with Aurora Technology Acquisition Corp., securing funding to enhance its global market presence in robotic and VR-enabled rehabilitation technology.
Market Concentration & Characteristics
The Exoskeleton Market shows a moderately concentrated structure with a few leading players holding significant market shares, while several regional and niche companies compete on technology and customization. It is characterized by rapid technological advancement, high development costs, and a strong focus on innovation. Companies prioritize product differentiation through lightweight designs, improved power efficiency, and AI-based mobility assistance. The market demands continuous research to meet evolving application needs in healthcare, industry, and defense. It faces strict regulatory standards, especially in medical use, which impacts time-to-market for new products. The market also shows a growing preference for mobile and lower body exoskeletons due to their operational flexibility and user-friendly design. Strategic collaborations and acquisitions are frequent as companies aim to strengthen their portfolios and global presence. The competitive landscape pushes manufacturers to invest in advanced materials and software integration to offer more affordable and efficient solutions. It remains highly sensitive to pricing, reimbursement policies, and safety certifications, which influence product accessibility across regions.
Report Coverage
The research report offers an in-depth analysis based on Mobility,Extremity, End-use, Technologyand Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The exoskeleton market is expected to witness steady growth driven by rising demand in healthcare, industrial, and military applications.
Increasing focus on patient rehabilitation and mobility assistance will continue to support the adoption of exoskeletons in medical settings.
Advancements in lightweight materials and battery technologies will improve device efficiency and user comfort.
Integration of artificial intelligence and smart sensors will make exoskeletons more responsive and adaptive to individual user needs.
Industrial sectors will increasingly adopt exoskeletons to enhance worker safety and reduce physical strain.
Growing military interest in performance-enhancing exoskeletons will open new growth opportunities.
The market will benefit from improving regulatory support and emerging reimbursement policies, especially in developed regions.
Expanding manufacturing capacities and cost optimization efforts will gradually improve product affordability.
Asia Pacific is likely to emerge as the fastest-growing region, supported by rising healthcare investments and industrialization.
Collaboration between technology providers and medical institutions will drive innovation and expand application areas.
CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews CHAPTER NO. 3 : EXOSKELETON MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown
3.6 Price Trend Analysis
3.6.1 Regional Price Trend
3.6.2 Price Trend by product CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Product Categories
4.3 Extremity Sweet Spots – Emerging Demand Segments CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Mobility & Extremity Revenue CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis by Region
6.1.1. Global Exoskeleton Market Import Volume By Region
6.2. Export Analysis by Region
6.2.1. Global Exoskeleton Market Export Volume By Region CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Global Exoskeleton Market: Company Market Share
7.1. Global Exoskeleton Market Company Volume Market Share
7.2. Global Exoskeleton Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024 CHAPTER NO. 8 : EXOSKELETON MARKET – BY MOBILITY SEGMENT ANALYSIS
8.1. Exoskeleton Market Overview by Mobility Segment
8.1.1. Exoskeleton Market Volume Share By Mobility
8.1.2. Exoskeleton Market Revenue Share By Mobility
8.2. Mobile
8.3. Fixed/Stationary CHAPTER NO. 9 : EXOSKELETON MARKET – BY EXTREMITY SEGMENT ANALYSIS
9.1. Exoskeleton Market Overview by Extremity Segment
9.1.1. Exoskeleton Market Volume Share By Extremity
9.1.2. Exoskeleton Market Revenue Share By Extremity
9.2. Upper Body
9.3. Lower Body
9.4. Full Body CHAPTER NO. 10 : EXOSKELETON MARKET – BY END-USE SEGMENT ANALYSIS
10.1. Exoskeleton Market Overview by End-use Segment
10.1.1. Exoskeleton Market Volume Share By End-use
10.1.2. Exoskeleton Market Revenue Share By End-use
10.2. Healthcare
10.3. Military
10.4. Industry CHAPTER NO. 11 : EXOSKELETON MARKET – BY TECHNOLOGY SEGMENT ANALYSIS
11.1. Exoskeleton Market Overview by Technology Segment
11.1.1. Exoskeleton Market Volume Share By Technology
11.1.2. Exoskeleton Market Revenue Share By Technology
11.2. Powered
11.3. Non-powered CHAPTER NO. 12 : EXOSKELETON MARKET – REGIONAL ANALYSIS
12.1. Exoskeleton Market Overview by Region Segment
12.1.1. Global Exoskeleton Market Volume Share By Region
12.1.2. Global Exoskeleton Market Revenue Share By Region
12.1.3. Regions
12.1.4. Global Exoskeleton Market Volume By Region
12.1.5. Global Exoskeleton Market Revenue By Region
12.1.6. Mobility
12.1.7. Global Exoskeleton Market Volume By Mobility
12.1.8. Global Exoskeleton Market Revenue By Mobility
12.1.9. Extremity
12.1.10. Global Exoskeleton Market Volume By Extremity
12.1.11. Global Exoskeleton Market Revenue By Extremity
12.1.12. End-use
12.1.13. Global Exoskeleton Market Volume By End-use
12.1.14. Global Exoskeleton Market Revenue By End-use
12.1.12. Technology
12.1.13. Global Exoskeleton Market Volume By Technology
12.1.14. Global Exoskeleton Market Revenue By Technology CHAPTER NO. 13 : NORTH AMERICA EXOSKELETON MARKET – COUNTRY ANALYSIS
13.1. North America Exoskeleton Market Overview by Country Segment
13.1.1. North America Exoskeleton Market Volume Share By Region
13.1.2. North America Exoskeleton Market Revenue Share By Region
13.2. North America
13.2.1. North America Exoskeleton Market Volume By Country
13.2.2. North America Exoskeleton Market Revenue By Country
13.2.3. Mobility
13.2.4. North America Exoskeleton Market Volume By Mobility
13.2.5. North America Exoskeleton Market Revenue By Mobility
13.2.6. Extremity
13.2.7. North America Exoskeleton Market Volume By Extremity
13.2.8. North America Exoskeleton Market Revenue By Extremity
13.2.9. End-use
13.2.10. North America Exoskeleton Market Volume By End-use
13.2.11. North America Exoskeleton Market Revenue By End-use
13.2.12. Technology
13.2.13. North America Exoskeleton Market Volume By Technology
13.2.14. North America Exoskeleton Market Revenue By Technology
13.3. U.S.
13.4. Canada
13.5. Mexico CHAPTER NO. 14 : EUROPE EXOSKELETON MARKET – COUNTRY ANALYSIS
14.1. Europe Exoskeleton Market Overview by Country Segment
14.1.1. Europe Exoskeleton Market Volume Share By Region
14.1.2. Europe Exoskeleton Market Revenue Share By Region
14.2. Europe
14.2.1. Europe Exoskeleton Market Volume By Country
14.2.2. Europe Exoskeleton Market Revenue By Country
14.2.3. Mobility
14.2.4. Europe Exoskeleton Market Volume By Mobility
14.2.5. Europe Exoskeleton Market Revenue By Mobility
14.2.6. Extremity
14.2.7. Europe Exoskeleton Market Volume By Extremity
14.2.8. Europe Exoskeleton Market Revenue By Extremity
14.2.9. End-use
14.2.10. Europe Exoskeleton Market Volume By End-use
14.2.11. Europe Exoskeleton Market Revenue By End-use
14.2.12. Technology
14.2.13. Europe Exoskeleton Market Volume By Technology
14.2.14. Europe Exoskeleton Market Revenue By Technology
14.3. UK
14.4. France
14.5. Germany
14.6. Italy
14.7. Spain
14.8. Russia
14.9. Rest of Europe CHAPTER NO. 15 : ASIA PACIFIC EXOSKELETON MARKET – COUNTRY ANALYSIS
15.1. Asia Pacific Exoskeleton Market Overview by Country Segment
15.1.1. Asia Pacific Exoskeleton Market Volume Share By Region
15.1.2. Asia Pacific Exoskeleton Market Revenue Share By Region
15.2. Asia Pacific
15.2.1. Asia Pacific Exoskeleton Market Volume By Country
15.2.2. Asia Pacific Exoskeleton Market Revenue By Country
15.2.3. Mobility
15.2.4. Asia Pacific Exoskeleton Market Volume By Mobility
15.2.5. Asia Pacific Exoskeleton Market Revenue By Mobility
15.2.6. Extremity
15.2.7. Asia Pacific Exoskeleton Market Volume By Extremity
15.2.8. Asia Pacific Exoskeleton Market Revenue By Extremity
15.2.9. End-use
15.2.10. Asia Pacific Exoskeleton Market Volume By End-use
15.2.11. Asia Pacific Exoskeleton Market Revenue By End-use
15.2.12. Technology
15.2.13. Asia Pacific Exoskeleton Market Volume By Technology
15.2.14. Asia Pacific Exoskeleton Market Revenue By Technology
15.3. China
15.4. Japan
15.5. South Korea
15.6. India
15.7. Australia
15.8. Southeast Asia
15.9. Rest of Asia Pacific CHAPTER NO. 16 : LATIN AMERICA EXOSKELETON MARKET – COUNTRY ANALYSIS
16.1. Latin America Exoskeleton Market Overview by Country Segment
16.1.1. Latin America Exoskeleton Market Volume Share By Region
16.1.2. Latin America Exoskeleton Market Revenue Share By Region
16.2. Latin America
16.2.1. Latin America Exoskeleton Market Volume By Country
16.2.2. Latin America Exoskeleton Market Revenue By Country
16.2.3. Mobility
16.2.4. Latin America Exoskeleton Market Volume By Mobility
16.2.5. Latin America Exoskeleton Market Revenue By Mobility
16.2.6. Extremity
16.2.7. Latin America Exoskeleton Market Volume By Extremity
16.2.8. Latin America Exoskeleton Market Revenue By Extremity
16.2.9. End-use
16.2.10. Latin America Exoskeleton Market Volume By End-use
16.2.11. Latin America Exoskeleton Market Revenue By End-use
16.2.12. Technology
16.2.13. Latin America Exoskeleton Market Volume By Technology
16.2.14. Latin America Exoskeleton Market Revenue By Technology
16.3. Brazil
16.4. Argentina
16.5. Rest of Latin America CHAPTER NO. 17 : MIDDLE EAST EXOSKELETON MARKET – COUNTRY ANALYSIS
17.1. Middle East Exoskeleton Market Overview by Country Segment
17.1.1. Middle East Exoskeleton Market Volume Share By Region
17.1.2. Middle East Exoskeleton Market Revenue Share By Region
17.2. Middle East
17.2.1. Middle East Exoskeleton Market Volume By Country
17.2.2. Middle East Exoskeleton Market Revenue By Country
17.2.3. Mobility
17.2.4. Middle East Exoskeleton Market Volume By Mobility
17.2.5. Middle East Exoskeleton Market Revenue By Mobility
17.2.6. Extremity
17.2.7. Middle East Exoskeleton Market Volume By Extremity
17.2.8. Middle East Exoskeleton Market Revenue By Extremity
17.2.9. End-use
17.2.10. Middle East Exoskeleton Market Volume By End-use
17.2.11. Middle East Exoskeleton Market Revenue By End-use
17.2.12. Technology
17.2.13. Middle East Exoskeleton Market Volume By Technology
17.2.14. Middle East Exoskeleton Market Revenue By Technology
17.3. GCC Countries
17.4. Israel
17.5. Turkey
17.6. Rest of Middle East CHAPTER NO. 18 : AFRICA EXOSKELETON MARKET – COUNTRY ANALYSIS
18.1. Africa Exoskeleton Market Overview by Country Segment
18.1.1. Africa Exoskeleton Market Volume Share By Region
18.1.2. Africa Exoskeleton Market Revenue Share By Region
18.2. Africa
18.2.1. Africa Exoskeleton Market Volume By Country
18.2.2. Africa Exoskeleton Market Revenue By Country
18.2.3. Mobility
18.2.4. Africa Exoskeleton Market Volume By Mobility
18.2.5. Africa Exoskeleton Market Revenue By Mobility
18.2.6. Extremity
18.2.7. Africa Exoskeleton Market Volume By Extremity
18.2.8. Africa Exoskeleton Market Revenue By Extremity
18.2.9. End-use
18.2.10. Africa Exoskeleton Market Volume By End-use
18.2.11. Africa Exoskeleton Market Revenue By End-use
18.2.12. Technology
18.2.13. Africa Exoskeleton Market Volume By Technology
18.2.14. Africa Exoskeleton Market Revenue By Technology
18.3. South Africa
18.4. Egypt
18.5. Rest of Africa CHAPTER NO. 19 : COMPANY PROFILES
19.1. Ekso Bionics
19.1.1. Company Overview
19.1.2. Product Portfolio
19.1.3. Financial Overview
19.1.4. Recent Developments
19.1.5. Growth Strategy
19.1.6. SWOT Analysis
19.2. ARMASTEC PTE. LTD
19.3. Hocoma
19.4. Lockheed Martin Corporation
19.5. Suit X
19.6. Rex Bionics Plc.
19.7. RB3D
19.8. ReWalk Robotics
19.9. Cyberdyne, Inc.
19.10. ActiveLink (Panasonic Corporation)
19.11. DIH Medical
Request Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current size of the Exoskeleton Market?
The Exoskeleton Market is valued at USD 480.13 million in 2024 and is projected to reach USD 1,585.31 million by 2032.
What are the key segments within the Exoskeleton Market?
The market is segmented by Mobility, Extremity, End-use, Technology, and Geography.
What are some challenges faced by the Exoskeleton Market?
High product costs, technical limitations, and strict regulatory requirements pose significant challenges to market growth.
Who are the major players in the Exoskeleton Market?
Major players include Ekso Bionics, ARMASTEC PTE. LTD, Hocoma, Lockheed Martin Corporation, Suit X, and Cyberdyne, Inc.
About Author
Sushant Phapale
ICT & Automation Expert
Sushant is an expert in ICT, automation, and electronics with a passion for innovation and market trends.
Wearable Robotic Exoskeleton Market size was valued at USD 1748.69 million in 2024 and is anticipated to reach USD 29516.22 million by 2032, at a CAGR of 42.37% during the forecast period (2024-2032).
The global Military Exoskeleton Market is expected to grow from USD 158.7 million in 2024 to USD 452.7 million by 2032, with a compound annual growth rate (CAGR) of 14.00% over the forecast period.
The Medical Exoskeleton market is projected to grow from USD 867.64 million in 2024 to USD 4813.25 million by 2032, reflecting a compound annual growth rate (CAGR) of 20.4%.
The Hand Rehabilitation Exercises Robotic Gloves Market is projected to grow from USD 285 million in 2024 to USD 624 million by 2032, registering a compound annual growth rate (CAGR) of 10.3% during the forecast period.
The Gait Trainer Market is expected to grow from USD 376.8 million in 2024 to USD 619.5 million by 2032, with a compound annual growth rate (CAGR) of 6.41%.
The KSA Soldier Modernization market is projected to grow from USD 2.81 million in 2024 to USD 3.67 million by 2032, reflecting a compound annual growth rate (CAGR) of 3.42%
The Mobility Aid Devices Market is projected to grow from USD 9709.7 million in 2024 to an estimated USD 15949.19 million by 2032, with a compound annual growth rate (CAGR) of 6.4% from 2024 to 2032.
The military wearables market is projected to grow from USD 4,201.5 million in 2024 to USD 5,363.81 million by 2032, registering a CAGR of 3.1% during the forecast period.
The global wearable robots market is anticipated to grow at a substantial CAGR of XX% in the upcoming years. The global wearable robots industry was estimated to be worth USD XX million in 2021 and was expected to be worth USD XX million by 2028.
Purchase Options
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
